These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 21920579)

  • 1. Effect of some parameters on the rate of the catalysed decomposition of hydrogen peroxide by iron(III)-nitrilotriacetate in water.
    De Laat J; Dao YH; El Najjar NH; Daou C
    Water Res; 2011 Nov; 45(17):5654-64. PubMed ID: 21920579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxyl radical involvement in the decomposition of hydrogen peroxide by ferrous and ferric-nitrilotriacetate complexes at neutral pH.
    Dao YH; De Laat J
    Water Res; 2011 May; 45(11):3309-17. PubMed ID: 21514949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics and mechanism of carbamazepine degradation by a modified Fenton-like reaction with ferric-nitrilotriacetate complexes.
    Sun SP; Zeng X; Lemley AT
    J Hazard Mater; 2013 May; 252-253():155-65. PubMed ID: 23518173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detailed spectroscopic, thermodynamic, and kinetic studies on the protolytic equilibria of Fe(III)cydta and the activation of hydrogen peroxide.
    Brausam A; Maigut J; Meier R; Szilágyi PA; Buschmann HJ; Massa W; Homonnay Z; van Eldik R
    Inorg Chem; 2009 Aug; 48(16):7864-84. PubMed ID: 19618946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel iron(III) porphyrazine complex. Complex speciation and reactions with NO and H2O2.
    Theodoridis A; Maigut J; Puchta R; Kudrik EV; van Eldik R
    Inorg Chem; 2008 Apr; 47(8):2994-3013. PubMed ID: 18351731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential role of hydrogen peroxide and organic hydroperoxides in augmenting ferric nitrilotriacetate (Fe-NTA)-mediated DNA damage: implications for carcinogenesis.
    Iqbal M; Sharma SD; Mizote A; Fujisawa M; Okada S
    Teratog Carcinog Mutagen; 2003; Suppl 1():13-21. PubMed ID: 12616593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic simulation studies on the transient formation of the oxo-iron(IV) porphyrin radical cation during the reaction of iron(III) tetrakis-5,10,15,20-(N-methyl-4-pyridyl)-porphyrin with hydrogen peroxide in aqueous solution.
    Saha TK; Karmaker S; Tamagake K
    Luminescence; 2003; 18(5):259-67. PubMed ID: 14587077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidation of sulfoxides and arsenic(III) in corrosion of nanoscale zero valent iron by oxygen: evidence against ferryl ions (Fe(IV)) as active intermediates in Fenton reaction.
    Pang SY; Jiang J; Ma J
    Environ Sci Technol; 2011 Jan; 45(1):307-12. PubMed ID: 21133375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic investigations of the reaction of an iron(III) octa-anionic porphyrin complex with hydrogen peroxide and the catalyzed oxidation of diammonium-2,2'-azinobis(3-ethylbenzothiazoline-6-sulfonate).
    Brausam A; Eigler S; Jux N; van Eldik R
    Inorg Chem; 2009 Aug; 48(16):7667-78. PubMed ID: 19601585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new insight into Fenton and Fenton-like processes for water treatment.
    Jiang C; Pang S; Ouyang F; Ma J; Jiang J
    J Hazard Mater; 2010 Feb; 174(1-3):813-7. PubMed ID: 19853996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ability of ferric nitrilotriacetate complex with three pH-dependent conformations to induce lipid peroxidation.
    Akai K; Tsuchiya K; Tokumura A; Kogure K; Ueno S; Shibata A; Tamaki T; Fukuzawa K
    Free Radic Res; 2004 Sep; 38(9):951-62. PubMed ID: 15621713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of oxygen concentrations on human fibroblasts treated with Fe(3+)-NTA.
    Pu H; Sakaguchi M; Kondo T; Kondo A; Kawabata T; Namba M
    Int J Mol Med; 2001 Mar; 7(3):295-300. PubMed ID: 11179510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of the effects of chloride, sulfate and nitrate ions on the rates of decomposition of H2O2 and organic compounds by Fe(II)/H2O2 and Fe(III)/H2O2.
    De Laat J; Truong Le G; Legube B
    Chemosphere; 2004 May; 55(5):715-23. PubMed ID: 15013676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics and mechanism of iron(III) complexation by ferric binding protein: the role of phosphate.
    Gabricević M; Anderson DS; Mietzner TA; Crumbliss AL
    Biochemistry; 2004 May; 43(19):5811-9. PubMed ID: 15134455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fenton-like oxidation of Rhodamine B in the presence of two types of iron (II, III) oxide.
    Xue X; Hanna K; Deng N
    J Hazard Mater; 2009 Jul; 166(1):407-14. PubMed ID: 19167810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient formation of the oxo-iron(IV) porphyrin radical cation during the reaction of iron(III) tetrakis-5,10,15,20-(N-methyl-4-pyridyl)porphyrin with hydrogen peroxide in aqueous solution.
    Saha TK; Karmaker S; Tamagake K
    Luminescence; 2003; 18(3):162-72. PubMed ID: 12701092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fenton-like degradation of MTBE: Effects of iron counter anion and radical scavengers.
    Hwang S; Huling SG; Ko S
    Chemosphere; 2010 Jan; 78(5):563-8. PubMed ID: 19959205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tannic acid inhibits in vitro iron-dependent free radical formation.
    Andrade RG; Ginani JS; Lopes GK; Dutra F; Alonso A; Hermes-Lima M
    Biochimie; 2006 Sep; 88(9):1287-96. PubMed ID: 16600466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of Fe(VI) in the treatment of Zn(II)-NTA complexes in aqueous solutions.
    Yang J; Tiwari D; Yu M; Pachuau L; Kim W; Lee S
    Environ Technol; 2010 Jun; 31(7):791-8. PubMed ID: 20586241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic studies on peroxide activation by a water-soluble iron(III)-porphyrin: implications for O-O bond activation in aqueous and nonaqueous solvents.
    Wolak M; van Eldik R
    Chemistry; 2007; 13(17):4873-83. PubMed ID: 17366654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.